Babar Ghias insider trades

Open-market stock purchases and sales by Babar Ghias, Chief Financial Officer at Biocryst Pharmaceuticals Inc, from SEC Form 4 filings since Jul 24, 2025.

Recent trades

DateStockTradeValue
Dec 17, 2025BCRX Biocryst Pharmaceuticals IncBought (not open market)—
Dec 17, 2025BCRX Biocryst Pharmaceuticals IncBought (not open market)—

Companies traded

  • BCRX Biocryst Pharmaceuticals Inc: other filings, last Dec 17, 2025

Get free alerts when Babar Ghias files a new trade →